Pheochromocytoma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
(→Images) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
==Pathophysiology== | ==Pathophysiology== | ||
Revision as of 15:05, 11 September 2012
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma pathophysiology |
|
Risk calculators and risk factors for Pheochromocytoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Pathophysiology
Traditionally it is known as the "10% tumor":
- bilateral disease is present in approximately 10% of patients
- approximately 10% of tumours are malignant
- approximately 10% are located in chromaffin tissue outside of the adrenal gland
- Approximately 10% arise in childhood
- Approximately 10% are familial
- Approximately 10% recur after being resected
- Approximately 10% patients do not have hypertension (Campbell's Urology)
Images
-
Micrograph of pheochromocytoma.
-
Micrograph of pheochromocytoma.
-
Micrograph of pheochromocytoma.
-
Bilateral pheochromocytoma in MEN2. Gross image.
_histopathology.jpg)
_histopathology.jpg)
_histopathology.jpg)
